SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-167921
Filing Date
2021-05-20
Accepted
2021-05-20 17:04:02
Documents
2
Period of Report
2021-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d185451d8k.htm 8-K 19694
2 EX-10.1 d185451dex101.htm EX-10.1 33263
  Complete submission text file 0001193125-21-167921.txt   54188
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39661 | Film No.: 21945304
SIC: 2834 Pharmaceutical Preparations